# ATLG Levels in Autologous HSCT for Multiple Sclerosis

> **NCT07635693** · — · RECRUITING · sponsor: **Ciceri Fabio** · enrollment: 20 (estimated)

## Conditions studied

- Multiple Sclerosis
- Autologous Hematopoietic Stem Cell Transplant
- ATLG

## Interventions

- **DRUG:** ATLG administration

## Key facts

- **NCT ID:** NCT07635693
- **Lead sponsor:** Ciceri Fabio
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-04
- **Primary completion:** 2028-05-04
- **Final completion:** 2029-05-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07635693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07635693, "ATLG Levels in Autologous HSCT for Multiple Sclerosis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07635693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*